Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus
Bristol Myers Squibb, the number 2 corporate patentee of cyclic-peptide technology after Bicycle, is interested in the peptides as treatments for cancer and infectious, inflammatory, and autoimmune diseases
Gut macrobiotic and hypertension Hypertension constitutes among the most prevalent CVDs (Yang et al., 2023), which is caused by a wide range of environmental and genetic factors (Kato et al., 2011), which already constitutes one of the main sources with respect to morbidity and mortality in the developed world
Tratamientos IML Clinic En IML contamos con las mejores tcnicas estticas para dar un servicio premium a nuestros pacientes
Prescription : If medication is necessary, your provider will send the prescription to a pharmacy for you to pick up or have delivered